Search results for "CSF"

showing 10 items of 48 documents

Images perceived after chromatic or achromatic contrast sensitivity losses.

2010

Purpose. We simulate how subjects with losses in chromatic and achromatic contrast sensitivity perceive colored images by using the spatiochromatic corresponding pair algorithm. Methods. This is a generalized version of the algorithm by Capilla et al. (J Opt Soc Am (A) 2004;21:176 –186) for simulating color perception of color deviant subjects, which incorporates a simple spatial vision model, consisting of a linear filtering stage, with a band-pass achromatic filter and two low-pass chromatic ones, for the red-green and blue-yellow mechanisms. These filters, except for the global scaling, are the subject’s contrast sensitivity functions measured along the cardinal directions of the color s…

Retinal Ganglion CellsBrightnessgenetic structuresColor visionmedia_common.quotation_subjectModels NeurologicalCorresponding pair algorithmColor spaceChromatic and achromatic CSFslaw.inventionContrast SensitivitylawImages simulationContrast (vision)HumansComputer visionChromatic scaleSensitivity (control systems)LightingÓpticaMathematicsmedia_commonbusiness.industryDiabetesColorfulnessGlaucomaOphthalmologyPattern Recognition VisualAchromatic lensArtificial intelligencebusinessColor PerceptionMathematicsOptometryOptometry and vision science : official publication of the American Academy of Optometry
researchProduct

Vasoactive peptide urotensin II in plasma is associated with cerebral vasospasm after aneurysmal subarachnoid hemorrhage and constitutes a potential …

2019

National audience; OBJECTIVECerebral vasospasm (VS) is a severe complication of aneurysmal subarachnoid hemorrhage (SAH). Urotensin II (UII) is a potent vasoactive peptide activating the urotensin (UT) receptor, potentially involved in brain vascular pathologies. The authors hypothesized that UII/UT system antagonism with the UT receptor antagonist/biased ligand urantide may be associated with post-SAH VS. The objectives of this study were 2-fold: 1) to leverage an experimental mouse model of SAH with VS in order to study the effect of urotensinergic system antagonism on neurological outcome, and 2) to investigate the association between plasma UII level and symptomatic VS after SAH in huma…

SAPS II = Simplified Acute Physiology Score IIMCA = middle cerebral arteryAUC = area under the curvesubarachnoid hemorrhage[SDV]Life Sciences [q-bio]ICU = intensive care unitUT = urotensin (receptor)vascular disordersintensive care unitUII = urotensin IIcardiovascular diseaseshumanmouseWFNS = World Federation of Neurosurgical SocietiesEVD = external ventricular drainageACA = anterior cerebral arteryurotensin IInervous system diseasesSAH = subarachnoid hemorrhageSE = standard errorROC = receiver operating characteristic[SDV] Life Sciences [q-bio]cerebral vasospasmVS = vasospasmDCI = delayed cerebral ischemiaCSF = cerebrospinal fluidIRB = institutional review boardmRS = modified Rankin ScaleIQR = interquartile range
researchProduct

Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders

2022

(1) Background: Alpha-synuclein (α-syn) is a presynaptic neuronal protein that regulates several neuronal functions. In recent decades, the role of α-syn as a biomarker of neurodegenerative diseases has been explored, especially in synucleinopathies. However, only a few studies have assessed its role as biomarker in other neurological disorders. The aim of the study was to evaluate cerebrospinal fluid (CSF) α-syn levels in several neurological disorders; (2) Methods: We measured CSF α-syn levels by a commercial ELISA kit in 158 patients classified in the following group: controls, Alzheimer’s Disease (AD), cerebrovascular diseases, inflammatory central nervous …

Settore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinicanervous systemparkinson’s diseaseneurodegenerationCSF; biomarker; parkinson’s disease; alzheimer’s disease; neurodegenerationbiomarkerCSFalzheimer’s diseaseGeneral Medicinenervous system diseasesJournal of Clinical Medicine
researchProduct

XPL, a Presentation Language based on User Interface Design Pattern

2007

The great diversity of presentations in software applications deals with fulfillment of various type of graphic interface constructions related to different programming Languages. Moreover, in the Internet era html pages play a main role because of the increasing complexity of Web applications. In Software Engineering, the use of design patterns is proven remarkable for the design and reuse of software components. Visual Design. Patterns (ViDP) are useful to define interaction schemas between. user and computer. By the some token, visual design. patterns are useful to incorporate common interfaces of interaction, schemas between user and computer. This paper describes the eXtensible Present…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniCommunication designbusiness.industryComputer scienceUser interface designSoftwareHigh-level programming languageHuman–computer interactionSoftware design patternComponent-based software engineeringUser interfacebusinessSoftware engineeringCommunicationComputer softwareComputer software reusabilityComputersCyberneticsFlow interactionsInformation managementInformation scienceGraphical user interface6th IEEE/ACIS International Conference on Computer and Information Science (ICIS 2007)
researchProduct

Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma.

1996

Settore MED/18 - Chirurgia GeneraleSettore MED/06 - Oncologia MedicaBreast carcinoma preoperative chemotherapy G.CSF
researchProduct

Is Sleep Disruption a Cause or Consequence of Alzheimer’s Disease? Reviewing Its Possible Role as a Biomarker

2020

In recent years, the idea that sleep is critical for cognitive processing has gained strength. Alzheimer’s disease (AD) is the most common form of dementia worldwide and presents a high prevalence of sleep disturbances. However, it is difficult to establish causal relations, since a vicious circle emerges between different aspects of the disease. Nowadays, we know that sleep is crucial to consolidate memory and to remove the excess of beta-amyloid and hyperphosphorilated tau accumulated in AD patients’ brains. In this review, we discuss how sleep disturbances often precede in years some pathological traits, as well as cognitive decline, in AD. We describe the relevance of sleep to memory co…

Sleep Wake Disorders0301 basic medicineswstau ProteinsReviewDiseaseNon-rapid eye movement sleepCatalysiscsf taulcsh:ChemistryInorganic Chemistry03 medical and health sciencesCognition0302 clinical medicineAlzheimer DiseaseMemoryremmedicineHumansDementiaPhysical and Theoretical ChemistryCognitive declinelcsh:QH301-705.5Molecular BiologySpectroscopyAmyloid beta-Peptidesbusiness.industryOrganic ChemistryCognitionGeneral Medicinemedicine.diseaseSleep in non-human animalsComputer Science Applicationsnremswa030104 developmental biologylcsh:Biology (General)lcsh:QD1-999Biomarker (medicine)Memory consolidationbusinessspindlesNeuroscienceBiomarkers030217 neurology & neurosurgerycsf amyloidInternational Journal of Molecular Sciences
researchProduct

Dynamics of a financial market index after a crash

2002

We discuss the statistical properties of index returns in a financial market just after a major market crash. The observed non-stationary behavior of index returns is characterized in terms of the exceedances over a given threshold. This characterization is analogous to the Omori law originally observed in geophysics. By performing numerical simulations and theoretical modelling, we show that the nonlinear behavior observed in real market crashes cannot be described by a GARCH(1,1) model. We also show that the time evolution of the Value at Risk observed just after a major crash is described by a power-law function lacking a typical scale.

Statistics and ProbabilityStatistical Finance (q-fin.ST)Index (economics)Actuarial scienceStatistical Mechanics (cond-mat.stat-mech)EconophysicsScale (ratio)Autoregressive conditional heteroskedasticityFinancial marketFOS: Physical sciencesQuantitative Finance - Statistical FinanceCrashFunction (mathematics)Condensed Matter PhysicsFOS: Economics and businessEconophysicsFinancial marketsCrashesValue at RiskEconometricsEconomicsCondensed Matter - Statistical MechanicsValue at riskPhysica A: Statistical Mechanics and its Applications
researchProduct

Chronic Adult Hydrocephalus

1974

Knowledge of Wallerian degeneration began in 1852 and, following experimental research on degeneration and regeneration of interrupted nerves, surgeons realized that reinnervation of end organs depended on growth of axons through the interrupted area of nerve. Therefore surgeons tried to reanastomose the stumps. Failures of reinnervation could not be blamed on lack of axoplasma metabolism and flow from cell body to suture line because the clinical observation of amputation neuromas and their constant recurrence demonstrated the unfailing delivery of axoplasma by the nerve cell body; at times to the deep concern of the surgeon, and the constant pain of the patient. The electron microscope sh…

Wallerian degenerationmedicine.medical_specialtymedicine.medical_treatmentObstructive hydrocephalusDegeneration (medical)Pressure rangeInternal medicineMedicineNeurochemistryAxonCsf shuntbusiness.industryVentricular dilatationRegeneration (biology)medicine.diseasenervous system diseasesHydrocephalusSurgerymedicine.anatomical_structureAxoplasmAmputationNormal csf pressureCardiologySubarachnoid spacebusinessReinnervation
researchProduct

Diagnostic use of monoclonal IgG antibody to meningococcal B polysaccharide in cerebrospinal fluid

1986

chemistry.chemical_classificationmedicine.medical_specialtybiologyGeneral MedicinePolysaccharideMicrobiologyMonoclonal IgGMicrobiologyMedical microbiologyMENINGOCOCCAL BCerebrospinal fluidchemistrymedicinebiology.proteinAntibodyMolecular BiologyCSF albuminAntonie van Leeuwenhoek
researchProduct

The use of Alzheimer CSF biomarkers in daily clinical practice

2020

medicine.medical_specialtyEpidemiologyBehavioral neurologybusiness.industryHealth PolicyNeuropsychiatrymedicine.diseaseClinical PracticePsychiatry and Mental healthCellular and Molecular NeuroscienceDevelopmental NeuroscienceCsf biomarkersmedicineDementiaNeurology (clinical)Geriatrics and GerontologyPsychiatrybusinessAlzheimer's & Dementia
researchProduct